Business Description
HilleVax Inc
NAICS : 541714
SIC : 2834
75 State Street, Suite 100 - 9995, Boston, MA, USA, 02109
Description
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.79 | |||||
Equity-to-Asset | -0.79 | |||||
Debt-to-Equity | -1.57 | |||||
Debt-to-EBITDA | -1.59 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 0 | |||||
Beneish M-Score | 0 |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.71 | |||||
9-Day RSI | 55.17 | |||||
14-Day RSI | 53.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.55 | |||||
Quick Ratio | 0.55 | |||||
Cash Ratio | 0.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -160.43 | |||||
ROIC % | -14.32 | |||||
ROC (Joel Greenblatt) % | -43101.3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -5.06 | |||||
EV-to-EBITDA | -5.06 | |||||
EV-to-FCF | -50.43 | |||||
Earnings Yield (Greenblatt) % | -19.78 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:HLVX
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0 | ||
EPS (TTM) ($) | -3.28 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 53.74 | ||
14-Day ATR ($) | 1.252254 | ||
20-Day SMA ($) | 12.8695 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 7.9 - 20.95 | ||
Shares Outstanding (Mil) | 33.43 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
HilleVax Inc Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |